{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T01:56:26Z","timestamp":1795139786672,"version":"4.10.3"},"reference-count":39,"publisher":"American Society of Hematology","issue":"22","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,11,26]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Preinfusion dim CD19 expression and rare CD19\u2013 events in B-ALL do not affect relapses or responses to CD19-directed CAR T-cells. Prior blinatumomab treatment increases the rate of failure to achieve MRD\u2013 remission and CD19\u2013 MRD and relapse.<\/jats:p>","DOI":"10.1182\/bloodadvances.2019000692","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T12:25:34Z","timestamp":1574252734000},"page":"3539-3549","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":200,"title":["CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy"],"prefix":"10.1182","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7126-6226","authenticated-orcid":false,"given":"Vinodh","family":"Pillai","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavitha","family":"Muralidharan","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhao","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asen","family":"Bagashev","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2177-5633","authenticated-orcid":false,"given":"Derek A.","family":"Oldridge","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7256-4572","authenticated-orcid":false,"given":"Jaclyn","family":"Rosenthal","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Van Arnam","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos J.","family":"Melenhorst","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7532-366X","authenticated-orcid":false,"given":"Diwakar","family":"Mohan","sequence":"additional","affiliation":[{"name":"Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"DiNofia","sequence":"additional","affiliation":[{"name":"Division of Oncology, Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5788-3962","authenticated-orcid":false,"given":"Minjie","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindhu","family":"Cherian","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Fromm","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Wertheim","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2739-2206","authenticated-orcid":false,"given":"Andrei","family":"Thomas-Tikhonenko","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Paessler","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl H.","family":"June","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9478-9211","authenticated-orcid":false,"given":"Eline T.","family":"Luning Prak","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2857-4092","authenticated-orcid":false,"given":"Vijay G.","family":"Bhoj","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan A.","family":"Grupp","sequence":"additional","affiliation":[{"name":"Division of Oncology, Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon L.","family":"Maude","sequence":"additional","affiliation":[{"name":"Division of Oncology, Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan R.","family":"Rheingold","sequence":"additional","affiliation":[{"name":"Division of Oncology, Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2019,11,18]]},"reference":[{"issue":"16","key":"2019112011300553800_B1","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N Engl J Med"},{"issue":"36","key":"2019112011300553800_B2","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1200\/JCO.2016.67.3301","article-title":"Phase I\/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed\/Refractory Acute Lymphoblastic Leukemia","volume":"34","author":"von Stackelberg","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"2019112011300553800_B3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nm.4441","article-title":"CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy","volume":"24","author":"Fry","year":"2018","journal-title":"Nat Med"},{"issue":"2","key":"2019112011300553800_B4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrclinonc.2017.176","article-title":"Acute lymphoblastic leukaemia in 2017: immunotherapy for ALL takes the world by storm","volume":"15","author":"Teachey","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"2019112011300553800_B5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"2019112011300553800_B6","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/s41591-018-0146-z","article-title":"Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia","volume":"24","author":"Orlando","year":"2018","journal-title":"Nat Med"},{"issue":"10","key":"2019112011300553800_B7","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/s41591-018-0201-9","article-title":"Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell","volume":"24","author":"Ruella","year":"2018","journal-title":"Nat Med"},{"issue":"11","key":"2019112011300553800_B8","doi-asserted-by":"crossref","first-page":"E352","DOI":"10.1002\/ajh.25235","article-title":"Heterogeneity of surface CD19 and CD22 expression in B lymphoblastic leukemia","volume":"93","author":"Rosenthal","year":"2018","journal-title":"Am J Hematol"},{"issue":"9","key":"2019112011300553800_B9","doi-asserted-by":"crossref","first-page":"e607","DOI":"10.1038\/bcj.2017.89","article-title":"Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A\/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis","volume":"7","author":"Haddox","year":"2017","journal-title":"Blood Cancer J"},{"issue":"7","key":"2019112011300553800_B10","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood-2012-06-438002","article-title":"Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia","volume":"121","author":"Haso","year":"2013","journal-title":"Blood"},{"issue":"1","key":"2019112011300553800_B11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2016-05-718395","article-title":"Resistance to anti-CD19\/CD3 BiTE in acute lymphoblastic leukemia may be mediated by disrupted CD19 membrane trafficking","volume":"129","author":"Braig","year":"2017","journal-title":"Blood"},{"issue":"1","key":"2019112011300553800_B12","doi-asserted-by":"crossref","first-page":"12320","DOI":"10.1038\/ncomms12320","article-title":"CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity","volume":"7","author":"Jacoby","year":"2016","journal-title":"Nat Commun"},{"issue":"3","key":"2019112011300553800_B13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/bloodadvances.2016000034","article-title":"Immunotherapy for cute lymphoblastic leukemia: from famine to feast","volume":"1","author":"Davis","year":"2016","journal-title":"Blood Adv"},{"issue":"1","key":"2019112011300553800_B14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/cyto.b.21239","article-title":"Principles of minimal residual disease detection for hematopoietic neoplasms by flow cytometry","volume":"90","author":"Wood","year":"2016","journal-title":"Cytometry B Clin Cytom"},{"issue":"1","key":"2019112011300553800_B15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cyto.b.21482","article-title":"A novel flow cytometric assay for detection of residual disease in patients with B-lymphoblastic leukemia\/lymphoma post anti-CD19 therapy","volume":"94","author":"Cherian","year":"2018","journal-title":"Cytometry B Clin Cytom"},{"issue":"9","key":"2019112011300553800_B16","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nbt.3942","article-title":"An atlas of B-cell clonal distribution in the human body","volume":"35","author":"Meng","year":"2017","journal-title":"Nat Biotechnol"},{"issue":"7","key":"2019112011300553800_B17","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.4049\/jimmunol.1800716","article-title":"Human Lymph Nodes Maintain TCF-1hi Memory T Cells with High Functional Potential and Clonal Diversity Throughout Life","volume":"201","author":"Miron","year":"2018","journal-title":"J Immunol"},{"issue":"13","key":"2019112011300553800_B18","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/bioinformatics\/btu138","article-title":"pRESTO: a toolkit for processing high-throughput sequencing raw reads of lymphocyte receptor repertoires","volume":"30","author":"Vander Heiden","year":"2014","journal-title":"Bioinformatics"},{"issue":"20","key":"2019112011300553800_B19","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1093\/bioinformatics\/btv359","article-title":"Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data","volume":"31","author":"Gupta","year":"2015","journal-title":"Bioinformatics"},{"key":"2019112011300553800_B20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jim.2015.10.009","article-title":"Discrimination of germline V genes at different sequencing lengths and mutational burdens: A new tool for identifying and evaluating the reliability of V gene assignment","volume":"427","author":"Zhang","year":"2015","journal-title":"J Immunol Methods"},{"key":"2019112011300553800_B21","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.3389\/fimmu.2018.01472","article-title":"Computational Evaluation of B-Cell Clone Sizes in Bulk Populations","volume":"9","author":"Rosenfeld","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"2019112011300553800_B22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/bioinformatics\/btw593","article-title":"ImmuneDB: a system for the analysis and exploration of high-throughput adaptive immune receptor sequencing data","volume":"33","author":"Rosenfeld","year":"2017","journal-title":"Bioinformatics"},{"issue":"17","key":"2019112011300553800_B23","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1158\/0008-5472.CAN-15-0159","article-title":"Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice","volume":"75","author":"Liu","year":"2015","journal-title":"Cancer Res"},{"issue":"12","key":"2019112011300553800_B24","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1158\/2159-8290.CD-15-1020","article-title":"Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy","volume":"5","author":"Sotillo","year":"2015","journal-title":"Cancer Discov"},{"issue":"7727","key":"2019112011300553800_B25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41586-018-0436-0","article-title":"The genetic basis and cell of origin of mixed phenotype acute leukaemia","volume":"562","author":"Alexander","year":"2018","journal-title":"Nature"},{"issue":"15","key":"2019112011300553800_B26","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood-2018-11-883710","article-title":"Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy","volume":"133","author":"Hay","year":"2019","journal-title":"Blood"},{"issue":"9967","key":"2019112011300553800_B27","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(14)61403-3","article-title":"T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial","volume":"385","author":"Lee","year":"2015","journal-title":"Lancet"},{"issue":"25","key":"2019112011300553800_B28","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood-2017-02-769208","article-title":"Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults","volume":"129","author":"Gardner","year":"2017","journal-title":"Blood"},{"issue":"10","key":"2019112011300553800_B29","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1158\/2159-8290.CD-18-0442","article-title":"Tumor Antigen Escape from CAR T-cell Therapy","volume":"8","author":"Majzner","year":"2018","journal-title":"Cancer Discov"},{"issue":"5","key":"2019112011300553800_B30","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1172\/JCI125423","article-title":"CD19 CAR T cell product and disease attributes predict leukemia remission durability","volume":"129","author":"Finney","year":"2019","journal-title":"J Clin Invest"},{"issue":"4","key":"2019112011300553800_B31","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.cll.2017.07.009","article-title":"Flow Cytometry in Pediatric Hematopoietic Malignancies","volume":"37","author":"Li","year":"2017","journal-title":"Clin Lab Med"},{"issue":"1","key":"2019112011300553800_B32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/pbc.20063","article-title":"CD19 negative precursor B acute lymphoblastic leukemia presenting with hypercalcemia","volume":"43","author":"Sultan","year":"2004","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"2019112011300553800_B33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cyto.b.21373","article-title":"CD19 negative precursor B acute lymphoblastic leukemia (B-ALL)-Immunophenotypic challenges in diagnosis and monitoring: A study of three cases","volume":"92","author":"Ghodke","year":"2017","journal-title":"Cytometry B Clin Cytom"},{"issue":"1","key":"2019112011300553800_B34","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1002\/ajh.24594","article-title":"Repeated loss of target surface antigen after immunotherapy in primary mediastinal large B cell lymphoma","volume":"92","author":"Yu","year":"2017","journal-title":"Am J Hematol"},{"issue":"12","key":"2019112011300553800_B35","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1182\/bloodadvances.2018018093","article-title":"Spontaneous reversion of a lineage switch following an initial blinatumomab-induced ALL-to-AML switch in MLL-rearranged infant ALL","volume":"2","author":"W\u00f6lfl","year":"2018","journal-title":"Blood Adv"},{"issue":"21","key":"2019112011300553800_B36","doi-asserted-by":"crossref","first-page":"e00383","DOI":"10.1128\/MCB.00383-18","article-title":"CD19 alterations emerging after CD19-directed immunotherapy cause retention of the misfolded protein in the endoplasmic reticulum","volume":"38","author":"Bagashev","year":"2018","journal-title":"Mol Cell Biol"},{"issue":"18","key":"2019112011300553800_B37","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1182\/blood-2017-09-804070","article-title":"Anti-CD19 resistance can \u201cstem\u201d from progenitors","volume":"130","author":"Shah","year":"2017","journal-title":"Blood"},{"issue":"18","key":"2019112011300553800_B38","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1182\/blood-2017-05-782888","article-title":"Hematopoietic stem cell involvement in BCR-ABL1+ ALL as a potential mechanism of resistance to blinatumomab therapy","volume":"130","author":"Nagel","year":"2017","journal-title":"Blood"},{"issue":"7750","key":"2019112011300553800_B39","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41586-019-1054-1","article-title":"CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape","volume":"568","author":"Hamieh","year":"2019","journal-title":"Nature"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/22\/3539\/1540328\/advancesadv2019000692.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/22\/3539\/1540328\/advancesadv2019000692.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T12:25:47Z","timestamp":1574252747000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/3\/22\/3539\/428808\/CAR-Tcell-therapy-is-effective-for-CD19dim"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,18]]},"references-count":39,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2019,11,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2019000692","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,18]]}}}